Effectiveness of 3% arbutin cream in the treatment of epidermal melasma
Keywords:
Efficacy, melasma, arbutinAbstract
Background: Melasma is a common acquired, circumscribed hypermelanosis of sun-exposed areas. Multiple treatment options are available for melasma but they require a long time to yield effective results. Arbutin has shown promising results in the treatment of melasma. The objective of this study was to determine the effectiveness of 3% arbutin cream in the treatment of epidermal melasma.
Patients and Methods: It was an interventional study conducted at the Department of Dermatology, Sir Ganga Ram Hospital, Lahore from 1st September, 2011 to 29th February, 2012. After approval from the Hospital Ethical Committee a total of 120 patients with epidermal melasma (diagnosed on Wood’s Lamp Examination), were enrolled in the study. All the patients were advised to apply 3% arbutin cream twice daily for 12 weeks. They were advised to do follow up visits every 2 weeks with a final visit 2 week after completion of treatment. Melasma Area Severity Index (MASI)1 score was calculated at the baseline and 2 weeks after completion of treatment period. Efficacy was measured by the decrease in MASI score (>50%). All the information was collected on a specially designed proforma. Photographs were taken at the start and end of study period.
Results: There were 7 (5.8%) male patients and 113 (94.2%) female patients in the study. The male to female ratio was 1:16.4. The mean age of patients was 33.93±6.1. In this study, 65 patients (54.16%) showed improvement in terms of >50% reduction in MASI score at 2 weeks follow up visit after the completion of treatment.
Conclusion: Use of arbutin 3% cream is an effective treatment modality in patients of epidermal melasma.
Downloads
Published
How to Cite
Issue
Section
License
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.
